Dual function of Lactobacillus kefiri DH5 in preventing high-fat-diet-induced obesity: direct reduction of cholesterol and upregulation of PPAR-α in adipose tissue

Molecular Nutrition and Food Research

Volumn 61, Issue 11, 2017, Pages

  Kim, Dong Hyeon ^a   Jeong, Dana ^a   Kang, Il Byeong ^a   Kim, Hyunsook ^b   Song, Kwang Young ^a   Seo, Kun Ho ^a  

^a Konkuk University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Cholesterol reduction; High fat diet; Lactobacillus kefiri; Obesity; PPAR

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; FABP4 PROTEIN, MOUSE; FATTY ACID BINDING PROTEIN; KEFIR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROBIOTIC AGENT;

ANIMAL; C57BL MOUSE; CHEMISTRY; CHOLESTEROL INTAKE; CLASSIFICATION; ENZYMOLOGY; FECES; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HYPERCHOLESTEROLEMIA; ISOLATION AND PURIFICATION; LACTOBACILLUS; LIPID DIET; MALE; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MOLECULAR TYPING; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOLOGY; RANDOMIZATION; SOUTH KOREA; VALIDATION STUDY; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ADIPOSITY; ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; CHOLESTEROL, DIETARY; DIET, HIGH-FAT; FATTY ACID-BINDING PROTEINS; FECES; GENE EXPRESSION REGULATION; HYPERCHOLESTEROLEMIA; KEFIR; LACTOBACILLUS; MALE; MICE, INBRED C57BL; MICROBIAL VIABILITY; MOLECULAR TYPING; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PPAR ALPHA; PROBIOTICS; RANDOM ALLOCATION; REPUBLIC OF KOREA;

EID: 85032657142     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201700252     Document Type: Article

References (44)

1. Miyoshi, M., Ogawa, A., Higurashi, S., Kadooka, Y., Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur. J. Nutr. 2014, 53, 599–606.
2. Tsai, Y. T., Cheng, P. C., Pan, T. M., Anti-obesity effects of gut microbiota are associated with lactic acid bacteria. Appl. Microbiol. Biotechnol. 2014, 98, 1–10.
3. Million, M., Angelakis, E., Paul, M., Armougom, F. et al., Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb. Pathog. 2012, 53, 100–108.
4. Tilg, H., Moschen, A. R., Kaser, A., Obesity and the microbiota. Gastroenterology 2009, 136, 1476–1483.
5. Iwashita, S., Tanida, M., Terui, N., Ootsuka, Y. et al., Direct measurement of renal sympathetic nervous activity in high-fat diet-related hypertensive rats. Life Sci. 2002, 71, 537–546.
6. Tanida, M., Shen, J., Maeda, K., Horii, Y. et al., High-fat diet-induced obesity is attenuated by probiotic strain Lactobacillus paracasei ST11 (NCC2461) in rats. Obes. Res. Clin. Pract. 2008, 2, 159–169.
7. Nakamura, F., Ishida, Y., Aihara, K., Sawada, D. et al., Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism in overweight and mildly obese individuals: a randomized controlled trial. Microb. Ecol. Health Dis. 2016, 27, 30312.
8. Nakamura, F., Ishida, Y., Sawada, D., Ashida, N. et al., Fragmented lactic Acid bacterial cells activate peroxisome proliferator-activated receptors and ameliorate Dyslipidemia in obese mice. J. Agric. Food Chem. 2016, 64, 2549–2559.
9. Ogawa, A., Kadooka, Y., Kato, K., Shirouchi, B. et al., Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects. Lipids Health Dis. 2014, 13, 1.
10. Forssten, S. D., Korczyńska, M. Z., Zwijsen, R. M., Noordman, W. H. et al., Changes in satiety hormone concentrations and feed intake in rats in response to lactic acid bacteria. Appetite 2013, 71, 16–21.
11. Emami, A., Bazargani, A., Dual effects of Lactobacilli as a cholesterol assimilator and an inhibitor of gastrointestinal pathogenic bacteria. Int. J. Enteric Pathog. 2014, 2, e15768.
12. Tsai, C. C., Lin, P. P., Hsieh, Y. M., Zhang, Z. Y. et al., Cholesterol-lowering potentials of lactic acid bacteria based on bile-salt hydrolase activity and effect of potent strains on cholesterol metabolism in vitro and in vivo. Sci. World J. 2014, 2014, 690752.
13. Chang, C. K., Wang, S. C., Chiu, C. K., Chen, S. Y. et al., Effect of lactic acid bacteria isolated from fermented mustard on immunopotentiating activity. Asian Pac. J. Trop. Biomed. 2015, 5, 281–286.
14. Madani, G., Mirlohi, M., Yahay, M., Hassanzadeh, A., How much in vitro cholesterol reducing activity of Lactobacilli predicts their in vivo cholesterol function? Int. J. Prev. Med. 2013, 4, 404–413.
15. Kim, D. H., Chon, J. W., Kim, H., Seo, K. H., Modulation of intestinal microbiota in mice by kefir administration. Food Sci. Biotechnol. 2015, 24, 1397–1403.
16. Kim, D. H., Kim, H., Jeong, D., Kang, I. B. et al., Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: Targeted and untargeted community analysis with correlation of biomarkers. J. Nutr. Biochem. 2017, 44, 35–43. https://doi.org/10.1016/j.jnutbio.2017.02.014
17. Lane, D. J., 16S/23S rRNA sequencing. in: Stackebrandt, E., Goodfellow, M. (Eds.), Nucleic Acid Techniques in Bacterial Systematics, John Wiley and Sons, Chichester 1991, pp. 115–147.
18. Hyronimus, B., Le Marrec, C., Hadj Sassi, A., Deschamps, A., Acid and bile tolerance of spore-forming lactic acid bacteria. Int. J. Food Microbiol. 2000, 61, 193–197.
19. Buck, L. M., Gilliland, S. E., Comparison of freshly isolated strains of Lactobacillus acidophilus of human intestinal origin for ability to assimilate cholesterol during growth. J. Dairy Sci. 1994, 77, 2925–2933.
20. Rudel, L. L., Morris, M. D., Determination of cholesterol using o-phthalaldehyde. J. Lipid Res. 1973, 14, 364–366.
21. Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C. et al., Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41, 1313–1321.
22. Farnworth, E.R., Mainville, I., Kefir: a fermented milk product. in: Farnworth, E. R. (Ed.), Handbook of Fermented Functional Foods, CRC Press, Boca Raton, FL 2003, pp. 77–112.
23. Tilg, H., Kaser, A., Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Invest. 2011, 121, 2126–2132.
24. Everard, A., Matamoros, S., Geurts, L., Delzenne, N. M. et al., Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice. mBio 2014, 5, e01011-e01014.
25. Arora, T., Singh, S., Sharma, R. K., Probiotics: interaction with gut microbiome and antiobesity potential. Nutrition 2013, 29, 591–596.
26. Roh, C., Jung, U., Screening of crude plant extracts with anti-obesity activity. Int. J. Mol. Sci. 2012, 13, 1710–1719.
27. Zeng, X. Y., Zhou, X., Xu, J., Chan, S. M. et al., Screening for the efficacy on lipid accumulation in 3T3-L1 cells is an effective tool for the identification of new anti-diabetic compounds. Biochem. Pharmacol. 2012, 84, 830–837.
28. Tomaro-Duchesneau, C., Jones, M. L., Shah, D., Jain, P. et al., Cholesterol assimilation by Lactobacillus probiotic bacteria: an in vitro investigation. BioMed Res. Int. 2014, 2014, 380316.
29. Al-Saleh, A. A., Metwalli, A. A. M., Abu-Tarboush, H. M., Bile salts and acid tolerance and cholesterol removal from media by some lactic acid bacteria and bifidobacteria. J. Saudi. Soc. Food Nutr. 2006, 1, 1–17.
30. Song, M., Yun, B., Moon, J. H., Park, D. J. et al., Characterization of selected Lactobacillus strains for use as probiotics. Korean J. Food Sci. Anim. Resour. 2015, 35, 551.
31. Song, M., Park, S., Lee, H., Min, B. et al., Effect of Lactobacillus acidophilus NS1 on plasma cholesterol levels in diet-induced obese mice. J. Dairy Sci. 2015, 98, 1492–1501.
32. Zhang, F., Qiu, L., Xu, X., Liu, Z. et al., Beneficial effects of probiotic cholesterol-lowering strain of Enterococcus faecium WEFA23 from infants on diet-induced metabolic syndrome in rats. J. Dairy Sci. 2017, 100, 1618–1628.
33. Goto, T., Lee, J. Y., Teraminami, A., Kim, Y. I. et al., Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. J. Lipid Res. 2011, 52, 873–884.
34. Kim, D. H., Kang, I. B., Jeong, D., Kim, H. et al., Development of rapid and highly specific TaqMan probe-based real-time PCR assay for the identification and enumeration of Lactobacillus kefiri in kefir milk. Int. Dairy J. 2016, 61, 18–21.
35. CODEX Alimentarius Commission 2003 CODEX standard for fermented milks. Codex Stan 243–2003. http://www.codexalimentarius.net/download/standards/400/CXS_243e.pdf
36. Pachikian, B. D., Essaghir, A., Demoulin, J. B., Catry, E. et al., Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways. Mol. Nutr. Food Res. 2013, 57, 347–359.
37. Goto, T., Kim, Y. I., Furuzono, T., Takahashi, N. et al., 10-oxo-12 (Z)-octadecenoic acid, a linoleic acid metabolite produced by gut lactic acid bacteria, potently activates PPARγ and stimulates adipogenesis. Biochem. Bioph. Res. Co. 2015, 459, 597–603.
38. Wakil, S. J., Abu-Elheiga, L. A., Fatty acid metabolism: target for metabolic syndrome. J. Lipid Res. 2009, 50(Supplement), S138-S143.
39. Hotamisligil, G. S., Bernlohr, D. A., Metabolic functions of FABPs — mechanisms and therapeutic implications. Nat. Rev. Endocrinol. 2015, 11, 592–605.
40. Rakhshandehroo, M., Knoch, B., Müller, M., Kersten, S., Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010, 2010, 612089.
41. Casteilla, L., Pénicaud, L., Cousin, B., Calise, D., Choosing an adipose tissue depot for sampling: factors in selection and depot specificity. Methods Mol. Bio. 2008, 456, 23–38.
42. Graf, D., Di Cagno, R., Fåk, F., Flint, H. J. et al., Contribution of diet to the composition of the human gut microbiota. Microb. Ecol. Health Dis. 2015, 26, 26164.
43. Flint, H. J., Scott, K. P., Louis, P., Duncan, S. H., The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepato. 2012, 9, 577–589.
44. Woting, A., Blaut, M., The intestinal microbiota in metabolic disease. Nutrients 2016, 8, 202.